Drug profile · INN
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS
- Patents linked
- 0
- News articles
- 0
Quick answer
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS) is an FDA-listed pharmaceutical active ingredient.
Key facts
Frequently asked questions
What is prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?
PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS is a marketed brand name for prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.